TECFIDERA for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 806 adverse event reports in the FDA FAERS database where TECFIDERA was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for TECFIDERA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Flushing | 2,385 | 23.0% | 0 | 75 |
| Nausea | 1,325 | 12.8% | 0 | 75 |
| Diarrhoea | 1,209 | 11.6% | 0 | 83 |
| Fatigue | 829 | 8.0% | 0 | 27 |
| Vomiting | 777 | 7.5% | 1 | 66 |
| Abdominal pain upper | 707 | 6.8% | 0 | 37 |
| Headache | 667 | 6.4% | 0 | 21 |
| Pruritus | 659 | 6.3% | 0 | 13 |
| Abdominal discomfort | 463 | 4.5% | 1 | 22 |
| Multiple sclerosis relapse | 461 | 4.4% | 0 | 140 |
| Asthenia | 395 | 3.8% | 1 | 34 |
| Dizziness | 383 | 3.7% | 0 | 13 |
| Malaise | 370 | 3.6% | 1 | 16 |
| Prescribed underdose | 362 | 3.5% | 0 | 22 |
| Gait disturbance | 356 | 3.4% | 0 | 27 |
Other Indications for TECFIDERA
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)